Neurogene Therapeutics
  • Home
  • About Us
  • Our Pipeline
  • Our Technology
  • Patients & Families
  • Expanded Access Policy
  • Careers
  • News
  • Contact Us
  • TWITTER
  • LINKEDIN
  • FACEBOOK

Focusing on the Future of Life-Changing
Genetic Medicines

Gene therapy holds incredible promise to revolutionize medical treatment. At Neurogene we believe that innovation, robust scientific execution, and a strong sense of purpose are required to turn this promise into reality. Our focus is to develop life-changing genetic medicines for people and their families impacted by devastating neurological diseases.

Learn More >>

OUR PIPELINE

We are building a gene therapy pipeline to help address the high unmet need for rare neurological diseases.

LEARN MORE

ABOUT US

At Neurogene, we are driven by a strong sense of purpose to advance genetic medicines.

LEARN MORE

LATEST NEWS

Neurogene Announces FDA Clearance of IND for NGN-401 Gene Therapy for Children with Rett Syndrome

Planned NGN-401 Phase 1/2 clinical trial to dose female pediatric patients with Rett syndrome in 2023 In a comprehensive preclinical…

Learn More

State of the Art Manufacturing

Neurogene owns and operates a state-of-the-art gene therapy manufacturing facility in Houston, Texas with fully integrated process and analytical development, and CGMP capabilities. We have developed two scalable AAV manufacturing processes (mammalian and insect cell-based production) to support preclinical studies and clinical trials.

LEARN MORE

Neurogene Inc.

Corporate Headquarters
535 W 24th Street, 5th Floor
New York, NY 10011

Manufacturing Headquarters
Houston, TX 77025
 

© 2023 Neurogene Inc.
GL-GEN-WEB-0002v4

Translation Disclaimer
  • Privacy
  • Terms of Use